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Background: Untreated congenital blindness through cataracts leads to lasting visual brain system changes,
including substantial alterations of extrastriate visual areas. Consequently, late-treated individuals (> 5 months
of age) with dense congenital bilateral cataracts (CC) exhibit poorer visual function recovery compared to individ-
uals with bilateral developmental cataracts (DC). Reliable methods to differentiate between patients with con-
genital and developmental cataracts are often lacking, impeding efficient rehabilitation management and
introducing confounds in clinical and basic research on recovery prognosis and optimal timing of surgery. A per-
sistent reduction of the P1wave of visual event-related potentials (VERPs), associatedwith extrastriate visual cor-
tical activity, has been reported in CC but not in DC individuals. Using two experiments, this study developed and
validated P1-based biomarkers for diagnosing a history of congenital blindness in cataract-reversal individuals.
Methods: Congenital and developmental cataract-reversal individuals as well as typically sighted matched con-
trols took part in a first experiment used for exploring an electrophysiological biomarker (NCC = 13, NDC = 13,
NControl = 26). Circular stimuli containing gratings were presented in one of the visual field quadrants while
visual event-related potentials (VERPs) were recorded. Two biomarkers were derived from the P1 wave of the
VERP: (1) The mean of the normalized P1 amplitude at posterior electrodes, and (2) a classifier obtained from a
linear support vector machine (SVM). A second experiment with partially new CC/DC individuals and their
matched controls (NCC = 14, NDC = 15, NControl = 29) was consecutively used to validate the classification based
on both biomarkers. Performance of the classifiers were evaluated using receiver operating characteristic
(ROC) curve analyses. All cataract-reversal individuals were tested after at least one year of vision recovery.
Findings: The normalized P1 amplitude over posterior electrodes allowed a successful classification of the CC
from the DC individuals and typically sighted controls (area under ROC curve, AUC = 0.803 and 0.929 for the
normalized P1 amplitude and the SVM-based biomarker, respectively). The validation for both biomarkers in
experiment 2 again resulted in a high classification success (AUC = 0.800 and 0.883, respectively for the nor-
malized P1 amplitude and the SVM-based biomarker). In the most conservative scenario involving classifica-
tion of CC from DC individuals in a group of only cataract-reversal individuals, excluding typically sighted
controls, the SVM-based biomarker was found to be superior to the mean P1 amplitude based biomarker
(AUC = 0.852 compared to 0.757 for the mean P1 based biomarker in validation). Minimum specificity
obtained was 80% across all biomarkers.
Interpretation: A persistent reduction of the P1 wave provides a highly specific method for classifying cataract
patients post-surgically as having suffered from bilateral congenital vs. bilateral developmental cataracts. We
suggest that using the P1 based non-invasive electrophysiological biomarker will augment existing clinical
classification criteria for individuals with a history of bilateral congenital cataracts, aiding clinical and basic
research, recovery prognosis, and rehabilitation efforts.
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Cataract is one of the leading causes of treatable childhood blind-
ness, with children from low-income countries bearing a dispropor-
tionate disease burden [1,2]. As the developing visual system is
Research in context
Evidence before this study
We searched PubMed on January 25, 2020, for articles pub-
lished in English, French, German, Hindi, Portuguese or Spanish,
without publication time constraints, using the terms (''child''
AND ''cataract'' AND (''diagnosis'' OR ''outcome'') AND (''VEP''
OR ''EEG'' OR ''VERP'' OR ''Evoked Potential'' OR ''Event-Related
Potential'')). One study involving visual event-related potentials
(VERPs) reported more severe visual deficits in children after a
history of congenital cataracts than for congenital squint, but
did not report any relationship between the electrophysiologi-
cal and clinical findings. Despite some studies applying preop-
erative VERP measures to predict postoperative visual acuities,
all in adults, we found none that used an age-independent
electrophysiological measure to differentiate congenital and
developmental etiologies in pediatric cataract populations.
Added value of this study
We report that a persistent reduction of the P1 wave in VERPs
can be used to develop age-independent electrophysiological
biomarkers for diagnosing a congenital vs. developmental etiol-
ogy of visual deprivation. To the best of our knowledge, this is
the first time that reported persistent changes in extrastriate
cortical processing has been used to derive non-invasive,
robust, and cost-sensitive biomarkers after sight restoration for
a history of congenital bilateral dense cataracts and congenital
pattern vision deprivation.
Implications of all the available evidence
An equal period of visual deprivation leads to substantially
graver and potentially permanent consequences for visual
recovery if it is congenital compared to when the deprivation is
developmental. Qualitatively different and more intense reha-
bilitation approaches are likely required for individuals with a
history of congenital bilateral visual deprivation compared to
those with a developmental deprivation. Without differentia-
tion between these two distinct types of visual deprivation, as
frequently observed in extant studies, both clinical and basic
research bear the risk of producing inconsistent and uninter-
pretable results. Electrophysiological methods as developed in
the present study could be a helpful tool for obtaining an inde-
pendent data point for determining the history of visual depri-
vation, aiding recovery prognosis and rehabilitation effort
planning as well as clinical and basic research in pediatric cata-
ract populations.
2 S. Sourav et al. / EClinicalMedicine 27 (2020) 100559especially susceptible to aberrant visual information [3], a transient
period of blindness which might have minimal effects in adults can
indelibly alter visual brain systems in children. Childhood cataracts
are therefore rigorously treated, since each week of additional visual
deprivation in the first 34 months of life markedly and persistently
reduces postsurgical visual acuity while increasing the probability of
developing strabismus and nystagmus [4,5]. Moreover, individuals
treated for congenital bilateral dense cataracts (CC), especially those
treated late (defined here as treated after the age of 5 months), fare
substantially worse than individuals treated for bilateral develop-
mental cataracts (DC), exhibiting not only persistently reduced
visual acuity after surgery [6,7], but additionally enduring signifi-
cant deficits in higher-level visual processing due to altered neu-
ral circuits [811]. DC individuals have been reported to attain
higher visual capabilities, partially close to the level of typically
sighted controls especially when transient visual deprivationoccurs sufficiently late so as to avoid sensitive periods in visual
development [9,12,13].
Despite the consensus for early intervention, children in develop-
ing countries are frequently diagnosed and operated later due to
infrastructural and socioeconomic factors. In India, the mean ages at
surgery for congenital and developmental cataracts have been
reported to be about 48 and 99 months respectively, with only 20% of
the CC children undergoing surgery within the first year of life [14].
Later treatment not only lowers the ceiling of visual recovery, partic-
ularly in CC individuals, but additionally increases the potential of
incorrect diagnosis of cataract onset e.g. due to symptom overlap at
presentation and in some cases, cataract absorption [15]. Expedited
intervention for cataracts causing significant vision reduction is
urged for later-diagnosed individuals regardless of congenital or
developmental etiology, but prognosis of postsurgical vision recovery
strongly depends on whether cataracts existed at birth or emerged
later. On the one hand, the visual system seems to have a remarkable
ability to recover basic visual functions even after long periods of
congenital blindness. For example, color discrimination and key
aspects of retinotopic processing in early visual areas have been
observed to recover to a relatively high level after congenital cataract
surgery [8,12,16]. On the other hand, persistent deficits in higher-
level visual processes, such as face and global motion processing,
have been reported after sight restoration following a history of con-
genital cataracts [9,17]. Late-treated CC individuals furthermore
require additional and more intensive rehabilitation efforts, an issue
that has to date often been neglected.
Categorizing congenital from developmental vision deprivation,
such as through cataracts, is of crucial importance for not only prog-
nosis, rehabilitation, and caregiving-related issues: A reliable classifi-
cation of late-treated cataract individuals additionally aids clinical
and basic research alike. Clinical studies investigate surgery or treat-
ment procedures for achieving optimal outcomes and examine fac-
tors that should receive consideration in multicenter studies to
obtain comparable results [1820]. Since surgery outcomes depend
on whether individuals with a history of congenital or developmental
cataracts were included, and since the relative number varies across
centers, the lack of well-stratified groups impedes reliable and valid
conclusions about treatment procedures. Thus, a highly specific clas-
sification using an identical electrophysiological biomarker across
patients would considerably improve clinical practice and research.
The availability of an electrophysiological biomarker would augment
initial clinical diagnosis procedures based on anamnestic information
from patients, parents and primary healthcare providers, if available,
as well as criteria such as the presence of nystagmus and type of stra-
bismus present [21,22].
Moreover, for basic research on the neural mechanisms of sensi-
tive periods in visual development, a reliable distinction between
congenital and developmental cataract patients is essential. The
increasing availability of noninvasive neuroscientific methods now
allows investigating neural circuit structures and functions and their
experience dependent development in humans [23]. However, unlike
in non-human animal research, where experience is systematically
manipulated, research involving humans must make use of natural
variations of visual experience during development. Thus, it is of
utmost importance to identify and investigate homogenous groups of
patients with regard to the onset and degree of visual deprivation.
For example, impairment of a visual or neural function after congeni-
tal but not developmental visual deprivation provides strong evi-
dence of an early sensitive period for the development of that
function, after which acquiring the skill and related brain functions
becomes difficult or is incomplete.
Due to incompleteness of patient information records and the
inherent difficulty of pinpointing an age of onset in individuals whose
cataracts were only treated months and years after onset, existing
research has often lumped congenital and developmental etiologies
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mental cataract [14], increasing the probability of confounding via
averaging effects across two distinct groups and thus deriving invalid
conclusions in both clinical and basic research. However, despite an
established history of using visual event-related potentials (VERPs)
for research and clinical use, an electrophysiological method for clas-
sifying congenital from developmental visual deprivation is yet lack-
ing.
We have recently demonstrated that the first cortical event-
related potential indexing retinotopic processing, the C1 wave, is
present in CC individuals and is elicited with a latency which was
indistinguishable between CC individuals and typically sighted con-
trols. Despite some alteration in scalp voltage distribution, the results
suggested a spared basic retinotopic organization of early visual cor-
tex (and associated visual processing) even after long periods of con-
genital pattern vision blindness [12]. By contrast, we found a strong
reduction of the group mean amplitude of the second, positive-going
P1 wave of the VERP in CC but not in DC individuals compared to nor-
mally sighted controls [9,12,24]. The P1 wave has been hypothesized
to be generated in extrastriate visual cortex [25], which non-human
primate work has suggested to be particularly sensitive to early
visual deprivation [26].
In two separate experiments involving simple high contrast grat-
ing stimuli, the present study investigated whether the P1 amplitude
can serve as an electrophysiological biomarker for distinguishing
individuals with a history of a transient congenital vs. developmental
phase of cataracts. In both EEG experiments, individuals operated for
either congenital or developmental bilateral cataracts, as well as typi-
cally sighted controls matched for age, sex, and handedness, saw
visual stimuli presented in a random order to one of the visual field
quadrants while they were engaged in a detection task. We hypothe-
sized that individuals treated for congenital cataracts can be distin-
guished from the individuals treated for developmental cataracts and
typically sighted controls based on the P1 amplitude, both with a
high sensitivity and specificity.
2. Methods
2.1. Participants
Experiments 1 and 2 developed and validated the electrophysio-
logical biomarkers, respectively. We aimed for 15 participants per
group based on a priori power analyses involving additional stimuli
not analyzed here. In experiment 1, 13 individuals with a history of
dense, total, and bilateral congenital cataracts and subsequent sight
restoration took part (CC; mean age = 17.85 years, range = 8 
37 years, 2 female, 1 left-handed). The process for classifying a partic-
ipant as CC started if bilateral dense cataracts at presentation were
observed including fundus invisibility, or if the participant had par-
tially absorbed cataracts, accompanied by nystagmus. Crucially,
anamnestic information from family members and primary health-
care providers, including family history and behavioral history of the
participant as a child, was used as corroborating evidence. The exis-
tence of strabismus, such as esotropia, additionally helped us classify
the CC individuals, in combination with all the other information
[27]. Participants were only included when a very high confidence in
the clinical diagnosis existed, and excluded otherwise. The mean
duration of blindness (= age of surgery) in the CC individuals was 38
months, ranging from 1 month to 17.75 years, and the mean time
since surgery was 15.08 years (range: 2.08  35.67 years). The mean
geometric visual acuity in the CC group was 0.251 (decimal, range:
0.051  0.7). A second group of 16 participants who had bilateral
developmental cataracts and had undergone cataract-removal sur-
gery took part in the study (DC group). The data of three of these par-
ticipants were rejected because of incomplete data acquisition (one
had a history of seizure and developmental delay, one wanted toabort the experiment shortly after the start and the third participant
was not able to look straight ahead). The remaining 13 participants
had a mean age of 16 years (range = 11  24 years, 5 female, all right-
handed). The age of the DC individuals did not significantly differ
from the CC individuals, two-tailed t-test, t(16.074) = 0.656, p = .521.
The geometric mean visual acuity in the DC group was 0.739 (deci-
mal, range = 0.44  1.00), and this group had a significantly better
visual acuity than the CC group (one-tailed t-test after converting the
acuities to LogMAR units, t(15.661) = 5.130, p < .001). The mean age
at surgery in the DC group was 9.78 years (range = 2  17.33 years)
and the mean time since surgery was 6.63 years (range = 1.42  22
years). Additionally, a group of 26 control participants matched for
age, sex, and handedness with a CC or DC participant took part in the
experiment (mean age = 17.04 years, range = 7  34 years, 7 female,
1 left-handed). All controls had normal or corrected-to-normal vision
and were free from sensory impairments. All subjects were free of
neurological problems as assessed by reports of the participants or
their legal guardians and a general clinical assessment in case of the
cataract reversal individuals. Although we matched the control par-
ticipants to individual participants from the CC or the DC group, for
classification purposes this group served as a homogenous partici-
pant group.
In experiment 2, used for validation, 15 participants with a history
of congenital cataracts took part. One of them was born with incom-
plete cataracts and therefore likely had some limited pattern vision
experience and was therefore excluded. The remaining 14 CC partici-
pants were on average 17.07 years old (range = 6  39 years). Three
of the CC participants in the second experiment were female and 1
was left-handed. The geometric mean visual acuity of the CC partici-
pants in the second experiment was 0.229 (decimal, range = 0.051 
0.7), and their mean age at surgery was 42.14 months (range = 1
month  17.75 years). The mean time since surgery in the CC group
in the second experiment was 13.92 years (range = 3.33  37 years).
The DC group of this experiment consisted of 16 individuals. Data of
one of these participants were left out of the analysis due to a history
of seizures and developmental delay. The remaining 15 DC partici-
pants had a mean age of 14.47 years (range = 9  24 years), and a
geometric mean visual acuity of 0.619 (decimal, range = 0.23  1.00).
This was significantly higher than the visual acuity of the CC group,
expressed in LogMAR units (one-tailed t-test, t(22.278) = 4.693, p <
.001). The age of the DC participants, however, was not significantly dif-
ferent from the CC participants, two-tailed t-test, t(16.696) = 0.908,
p = .377. Four participants were female, and one was left-handed. The
mean age at surgery for the DC group was 7.36 years (range = 1.92 
14.42 years), and the mean time since surgery was 7.52 years
(range = 4.58  22 years). As in the first experiment, a group of partici-
pants matched for age, sex, and handedness to the cataract-reversal par-
ticipants took part in the study (N = 29, mean age = 15.66 years,
range = 7  38 years, 7 female, 2 left-handed). All of them had normal
or corrected-to-normal vision and no history of sensory problems. The
second experiment had 3 new CC and 7 new DC individuals who did
not partake in the first experiment, that is, 34% new individuals with a
history of cataracts (see Fig. 1). Five control participants who took part
in experiment 1 took part in experiment 2 as well, and the rest (83%, 24
out of 29) were new.
All CC and DC participants were recruited and tested at the L V
Prasad Eye Institute, Hyderabad, India (LVPEI). Control participants
were from the local community of Hamburg (see Fig. 1 for participant
flow diagram according to the Standards for Reporting of Diagnostic
Accuracy, STARD). For taking part in the study, adult participants
received a small monetary compensation and minors received a pres-
ent. The study was approved both by the local ethics commission of
the faculty of Psychology and Human Movement at the University of
Hamburg and the institutional ethics review board of LVPEI, and con-
formed to the ethical principles outlined in the Declaration of Hel-
sinki (2013).
Fig. 1. A. Standards for Reporting of Diagnostic Accuracy (STARD) flow diagram for P1 amplitude based diagnostic biomarker development (experiment 1), and B. Validation in
experiment 2 with classification thresholds developed from experiment 1. C. Venn diagram showing participant overlap in the two experiments (CC: Participants with a history of
congenital dense bilateral cataracts and subsequent vision restoration, DC: Participants with a history of bilateral developmental cataracts and subsequent vision restoration).
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In both experiments, all participants were presented with circular
visual stimuli subtending a visual angle of 2.5° presented in one of
the four quadrants of the visual field on a gray background as
depicted in Fig. 2. The eccentricity of the center of the stimuli was 4°
and the stimuli consisted of either horizontally (P = .80) or vertically
oriented (P = .20) monochromatic square wave grating patterns. The
spatial frequency of the gratings was 2 cycles/degree, which was
within the range of spatial frequencies reported to be affected least
in congenital cataract reversal individuals (0.33  2 cycles/degree)
[28]. The stimuli were presented for a duration of 150 ms with a
mean interstimulus interval of 1.85 s (range = 1.5  2.2 s). The loca-
tions were chosen to optimally stimulate opposing locations in the
upper and lower banks of the calcarine sulcus and are widely used in
studies investigating retinotopic processing in humans [25]. VERPs
elicited by pattern onset stimuli as employed in the current study, in
contrast to VERPs elicited by pattern reversal stimuli, have been
reported not to be suppressed by nystagmus [29,30]. This aspect
makes them especially suitable for being employed in the CC popula-
tion, as nystagmus is one of the common sequelae associated with
(transient) congenital visual deprivation [4,5].
Participants responded to the infrequently presented vertically
oriented patterns using a foot pedal in experiment 1 and with a
mouse in experiment 2 (for details, see Supplementary Materials S2:Behavioral Data Analysis). Two CC participants in experiment 1, and 2
DC participants and 1 CC participant in experiment 2 were not able
to discriminate the grating orientations and observed the stimuli pas-
sively. The ability of these participants to accurately perceive the
quadrant of stimulus appearance was tested in all cases. Before the
commencement of the experiment, participants received a practice
block. The stimuli were presented at the L V Prasad Eye Institute on a
Dell IN2030 Monitor and at the University of Hamburg on a Samsung
P2370 monitor, both of which had a refresh rate of 60 Hz and a nomi-
nal luminance value of 250 cd/m2. In the first experiment, the partici-
pant sat at a distance of 45 cm from the monitor and in the second, at
a distance of 65 cm. The angular measurements were, however,
exactly the same. For stimulus presentation and EEG triggering we
used the PsychoPy framework (version 1.83) [31]. Both experiments
comprised additional stimuli not analyzed here. Part of the data from
experiment 1 have been published elsewhere [12].
For EEG data acquisition, a custom cap from EASYCAP was used
with Ag/AgCl electrodes with a left earlobe reference (EASYCAP
GmbH, Herrsching, Germany), and average referenced offline. The
recording locations, based on the standard 10/20 system, were the
following: FP1, FP2, F7, F3, Fz, F4, F8, FC5, FC1, FCz, FC2, FC6, T7, C3,
Cz, C4, T8, TP9, CP5, CP1, CP2, CP6, TP10, P7, P3, Pz, P4, P8, O1, O2, F9,
and F10. EEG data were recorded using BrainVision BrainAmp DC/MR
Amplifiers (Brain Products GmbH, Gilching, Germany), through an
online bandpass filter with cutoff frequencies of 0.016 Hz and
Fig. 2. Visual stimulus locations used in the two experiments. The stimuli were pre-
sented randomly and one at a time, with rare vertical gratings serving as behavioral
targets.
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notch-filtered for electrical line noise artefacts at 50 Hz and its har-
monics if sharp peaks were present at the frequency spectrum of the
data. Following this, biological artefacts related to blinks, saccades,
heartbeats and excessive muscle activity were removed with an inde-
pendent components analysis using the EEGLAB framework running
on MATLAB (EEGLAB version: 11.5.4b, MATLAB version 2012b; Math-
Works, Natick, MA) [32]. Before averaging, EEG epochs with blinks or
eye movements in the time window of 25 ms to 175 ms with
respect to the stimulus onset were marked for rejection to prevent
potential VERP reductions caused by eye movements or blinks during
stimulus presentation. For this purpose, we analyzed the separated
blink and eye movement independent components, if present, using
their stereotypical topographies [33,34]. The maximum of five times
the standard deviations of the frontopolar electrodes FP1 and FP2
provided the threshold value for detecting blinks, and the maximum
of 3 times the standard deviations of the electrodes F9 and F10 were
used as the threshold of detecting eye movements. In the separated
blink and eye movement independent components data, that is, data
containing the major ocular artefacts, signal values exceeding the
absolute value of these thresholds were rejected. The data were then
epoched from 1000 ms prior to 1000 ms after the onset of visual
stimulation after average referencing and low-pass filtering with a
cut-off frequency of 40 Hz. To increase power, for EEG trials gener-
ated by left visual field stimulation, we swapped the data of each
electrode with the data of the electrode in its mirrored location with
respect to the nasion-inion axis, leaving the midline electrodes
untouched, as was used in already published work [12]. To exclude
contamination from motor artefacts from possible responses, we
rejected epochs which contained a button response within 500 ms of
the stimulus onset for participants who operated the response devi-
ces themselves. Finally, visual event-related potentials (VERPs) were
calculated by averaging the trials for each time point, yielding two
VERPs per participant, one for upper visual field and one for lower
visual field stimuli. In experiment 1, the mean number of artifact-free
trials for the upper visual field stimulus condition was 128
(SE = 5.106), with a minimum value of 40 trials. In experiment 2, the
mean number of artifact-free trials from upper visual field stimula-
tion entering the analyses was 81 (SE = 4.539), with a minimum of 21
trials.
2.3. Biomarker development and statistical analysis
We used data exclusively from the first experiment for the devel-
opment of the P1 wave based biomarker for congenital visual depri-
vation. To determine the P1 wave latency, in each single participantand condition (upper and lower visual fields), we first identified the
largest P1 wave peak separately at each of the 13 electrodes posterior
to the midline (TP9, CP5, CP1, CP2, CP6, TP10, P7, P3, Pz, P4, P8, O1,
and O2) in a 100  200 ms post-stimulus time window using the find-
peaks function in MATLAB. The latency for an individual and condi-
tion was determined at the electrode at which the highest P1 wave
peak was observed. To prevent detecting spurious peaks found by
the algorithm, we calculated the mean P1 amplitude in a 50 ms win-
dow centered at each individual’s latency. Five participants, all of
them CC, displayed a negative value for the average P1 amplitude for
both upper and lower visual field stimulation in this window  a
numerical absence of the P1 wave  and were therefore excluded
from latency calculations. Thereafter, for each of the three groups
(CC/DC/Control), we separately calculated the average P1 wave
latency for the upper and lower visual field stimulus conditions. The
average latency of the P1 wave over all the three groups and both
stimulus locations was 145 ms (range: 139  155 ms). In the typically
sighted controls, we ran a two-tailed cluster-based permutation test
using FieldTrip software over the 13 electrodes posterior to the mid-
line (where the P1 wave is most discernible) and a latency range of
50 ms centered at this P1 peak latency to test whether visual field
location (upper vs. lower) had an effect on the P1 amplitude [35]. The
cluster-based permutation test revealed that P1 amplitudes elicited
by upper visual field stimuli were significantly larger than for lower
visual field stimulations (10,000 permutations, p < .001). We there-
fore used VERPs to upper visual field stimuli for the development of
the biomarkers.
As a first step for developing a P1-based biomarker, for each indi-
vidual participant we extracted the mean of the VERP amplitude in
the range of 120  170 ms, that is, in a 50 ms period centered at the
mean P1 peak. VERP amplitudes in children are considerably higher
than in adults, but the topography of ERP waves have been reported
to be remarkably stable across age groups from the 4th year of life
[36]. To remove age as a confounding factor, we converted the mean
P1 amplitude to standard scores calculated across all electrodes, a
topography-preserving procedure that normalizes amplitude [37].
Thereafter we developed two biomarkers from the standardized P1
wave topography. The first, the mean posterior P1 biomarker (MPP1),
was obtained by simply taking the mean of the normalized P1 wave
amplitude over the 13 posterior electrodes (TP9, CP5, CP1, CP2, CP6,
TP10, P7, P3, Pz, P4, P8, O1, O2; see Fig. 3). To verify the reduction of
P1 amplitudes in the CC group, we submitted the MPP1 values to an
ordinary least squares linear model with MPP1 values as the depen-
dent variable and Group (CC/DC/Control) as the categorical predictor
in the R programming environment, version 3.6.1 [38]. For this analy-
sis, the control group was set as the reference group.
The development procedure for the MPP1 biomarker was equiva-
lent to weighting each of the posterior electrodes by a factor of 113 and
performing a sum. To explore whether other linear weighting strate-
gies might lead to a classification improvement, we additionally sub-
mitted the normalized P1 wave amplitude values from the posterior
electrodes of all participants from the three groups (CC/DC/Control)
to a linear support vector machine (SVM) returning the optimum
weight for each electrode for classifying CC individuals (see Fig. 4,
panel C) [39,40]. The optimum value for the cost hyperparameter of
the linear SVM-based biomarker was derived through grid search
using the e1071 library, version 1.72 [41], in the R programming
environment, version 3.6.1 [38]. This classifier derived from a linear
support vector machine was termed SVMP1. Both the MPP1 and the
SVMP1 biomarkers were submitted to receiver operating characteris-
tics (ROC) analyses for determining the optimum cut-off point for the
classification, maximizing the Youden’s J parameter which indicates
the vertical distance from the diagonal chance performance line (see
Fig. 4) [42]. Stratified bootstrap tests (n = 2000) were used to compare
the area under the ROC curves (AUCs) of the biomarkers. Statistical
analyses were performed with the pROC package, version 1.15.3 [43],
Fig. 3. Development and validation of an electrophysiological biomarker for classifying sight recovered bilateral congenital vs. bilateral developmental cataract individuals. A. Visual
event-related potentials (VERPs) to upper visual field stimuli from experiment 1 were used for classifier development. The VERPs at electrode P8 is depicted for all three groups.
Shaded colored areas show the standard error of the mean. We first extracted the mean P1 amplitude over a 50 ms time range around the average P1 latency (note that electrodes
below the nasion-inion “great circle” are depicted outside the head circumference). Thereafter, we normalized the P1 amplitude over the whole electrode montage and calculated
the mean value over the posterior electrodes as a biomarker (Mean posterior P1, MPP1). We created an additional biomarker by employing a linear support vector machine to find
the optimum linear coefficients for classifying CC individuals (SVMP1). Receiver operating characteristics analysis was used to find optimum threshold values, maximizing the You-
den’s J parameter. B. Validation of the classification algorithm. VERPs to upper visual field stimuli were obtained from a separate experiment using a different viewing distance. The
biomarkers MPP1 and SVMP1 for congenital cataract history were obtained for each individual and classification performance was measured using the thresholds obtained from
the first experiment.
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sion 3.6.1 [38]. Confidence intervals for the AUCs were calculated
employing the DeLong’s method [44].
For validation, we exclusively used the VERPs from the second
experiment. For each participant taking part in the second experi-
ment, we calculated the MPP1 and SVMP1 classification scores as
outlined above. For defining the SVMP1 classifier, the weights
derived from experiment 1 were used. Classification performance
was assessed by utilizing the thresholds obtained from the first
experiment to classify the MPP1 and SVMP1 values of the second
experiment. We additionally developed and validated the classifica-
tion in a combined group of only CC and DC individuals excluding the
typically sighted controls, since the most conservative and crucial
scenario involves classification of CC from DC individuals.
To examine potential effects of visual recovery period as well as
age at surgery on the classification accuracy, we ran four logistic
regression models, two for each experiment, with classification suc-
cess from the MPP1 or the SVMP1 biomarker as the dependent vari-
able, and time since surgery (in months, normalized) and age atsurgery (in months, normalized) as the independent variables. With-
out scaling (or more appropriately, centering) the independent varia-
bles, the intercept from the logistic regression model would provide
the log likelihood of accurate responses when the independent varia-
bles, mean age at surgery (months) and mean time since surgery
(months), were both zero, which cannot be directly interpreted. After
scaling the independent variables, the intercept in this model pro-
vided the classification accuracy at the mean age of surgery and the
mean duration of visual recovery, and the regression coefficients rep-
resented an estimate of the departure from this level of accuracy as a
function of age at surgery or time since surgery (in months).
The article adheres to the STROBE guidelines [45].
3. Role of the funding sources
The funding sources did not play any role in the study design, data
collection, data analysis, interpretation of the data, writing of the arti-
cle or in the decision to submit the article for publication except by
providing financial support to fund the scientists and research. The
Fig. 4. Development and validation of the P1-based biomarkers for classifying congenital cataract individuals. A. Receiver operating characteristic (ROC) curve from the first experi-
ment involving all three groups classifying CC individuals using the MPP1 marker. B. ROC curve from experiment 1 for the SVMP1 marker. C. Optimal linear weights for the posterior
electrodes for SVM-based classification, plotted as a topography (unitless). D. and E. ROC curves for MPP1 and SVMP1 based classification for experiment 2. F. ROC curve for the
SVMP1 validation performance in experiment 2 with weights developed from a group of only CC and DC individuals in experiment 1, applied for the combined group of only CC and
DC individuals in experiment 2. G. and H. ROC curves for experiment 2 as in panels D. and E., but with only the new CC and DC participants (NCC = 3, NDC = 10, NControl = 29). Each
panel displays the areas under the ROC curves (AUCs) and their 95% confidence intervals (CIs). CI bands for sensitivities are depicted as shaded areas (all sensitivity CIs obtained
with stratified bootstraps, n = 2000). All ps < .05 for the ROCs. For statistical details see Table 1.
S. Sourav et al. / EClinicalMedicine 27 (2020) 100559 7corresponding author had full access to the collected data and had
final responsibility for the decision to submit for publication, with
the consent of all co-authors.
4. Results
In the first experiment, used for developing the electrophysiologi-
cal biomarkers, employing an ordinary least squares linear model we
found that normalized posterior P1 amplitude (MPP1) values were
significantly different across groups, F(2, 49) = 14.591, p < .001,
R2adj = .348. While the DC group was not significantly different from
the control participants (bDC = 0.137, 95% CI = [0.430, 0.156],
SEDC = 0.146, p = .351), the CC group exhibited a very large [46], statis-
tically significant reduction of MPP1 values, bCC = 0.777,standardized b = 1.462, 95% CI = [1.070, 0.484], SECC = 0.146, p <
.001. The very large reduction of the normalized posterior P1 ampli-
tudes in the CC group was replicated in experiment 2, F(2,
55) = 12.479, p < .001, R2adj = .287, bCC = 0.654, standardized
b = 1.354, 95% CI = [0.919, 0.388], SECC = 0.133, p < .001. The DC
group was once more indistinguishable from the control participants,
bDC = 0.112, 95% CI = [0.372, 0.148], SEDC = 0.130, p = .391.
The ROC analysis involving all three groups indicated that both
MPP1 and SVMP1 classifiers exhibited excellent performance for
identifying congenital pattern vision deprivation (areas under the
ROC curve, AUCs > 0.8, see Fig. 4 and Table 1: Development) [47].
The SVMP1 biomarker showed a higher performance than the MPP1
biomarker (stratified bootstrap test, D = 2.330, n = 2000, p = .020,
see also Table 1: Development). This was not unexpected, since the
Table 1
Classifier performance. For the mean posterior P1 (MPP1) and the linear support vector machine based P1 (SVMP1) biomarkers, key classification parameters for the develop-
ment and validation are shown: Area under the ROC curve (AUC), sensitivity, specificity, and likelihood ratios.
Development (Experiment 1)
AUC(95%CI) Sensitivity Specificity Positive Likelihood Ratio Negative Likelihood Ratio
MPP1 0.803 (0.627  0.979) 0.769 0.846 4.99 0.27
SVMP1 0.929 (0.846  1.000) 0.846 0.897 8.21 0.17
Validation (Experiment 2. Sensitivity and specificity obtained using the classification threshold values generated from Experiment 1)
AUC(95%CI) Sensitivity Specificity Positive Likelihood Ratio Negative Likelihood Ratio
MPP1 0.800 (0.641  0.960) 0.643 0.909 7.07 0.39
SVMP1 0.883 (0.775  0.992) 0.786 0.864 5.78 0.25
Validation with only CC and DC individuals in Experiment 2. Sensitivity and specificity obtained using thresholds from Experiment 1 with only CC and DC individuals
AUC(95%CI) Sensitivity Specificity Positive Likelihood Ratio Negative Likelihood Ratio
MPP1 0.757 (0.568  0.946) 0.643 0.800 3.22 0.45
SVMP1 0.852 (0.711  0.994) 0.857 0.800 4.29 0.18
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classify the CC participants. The optimal weights for the linear SVM-
based classification are depicted as a topography in Fig. 4, panel C.
The optimum threshold maximizing the Youden’s J parameter for the
MPP1 classifier was 0.408 (z-score) [42], and for the SVMP1 classifier
the optimum threshold was 0.830 (linear weighted z-score).
A validation of the ROC analyses with data from experiment 2 of
all three groups (CC/DC/Control) using classification thresholds
obtained from experiment 1 indicated a reliable classification perfor-
mance for both the MPP1 and the SVMP1 classifiers (AUCs > 0.8, see
Table 1: Validation). Importantly, both classifiers exhibited excellent
specificity (90.9% for the MPP1 and 86.4% for the SVMP1 biomarker).
The SVMP1 biomarker exhibited a better classification performance
than the MPP1 biomarker, indicated by a significantly higher AUC of
its ROC curve (stratified bootstrap test, D = 1.989, n = 2000,
p = .047). Moreover, keeping only the sight recovery participants who
took part in experiment 2 but not in experiment 1 (NCC = 3, NDC = 10,
NControl = 29) impressively demonstrated the reliability of both bio-
markers (see Fig. 4, panels G and H). Compared to MPP1 biomarker,
AUC = 0.759, 95% CI = [0.501  1.00], the SVMP1 biomarker per-
formed better, AUC = 0.944, 95% CI = [0.861  1.00], stratified boot-
strap test with 2000 replicates, D = 1.980, p = .048. Using the
threshold value from experiment 1, in this conservative test all of the
3 new CC participants in experiment 2 were detected by the SVMP1
biomarker with a sensitivity of 100%, while retaining a high specific-
ity of 88.89%.
We additionally tested and verified the performance of the MPP1
and the SVMP1 in a group comprising only the CC and the DC individ-
uals. The validation tests in experiment 2 indicated a higher perfor-
mance of the SVMP1 classification method (NCC = 14, NDC = 15,
sensitivity = 85.7%, specificity = 80.0%) compared to the MPP1
(sensitivity = 64.3%, specificity = 80.0%), but statistically only a trend
for a higher AUC was observed (stratified bootstrap test, D = 1.874,
n = 2000, p = .061; see Table 1: Validation with only CC and DC indi-
viduals). At an individual level, a sensitivity of 85.7% (=12/14) signi-
fies that only 2 of the 14 CC participants were misclassified. Likewise,
a specificity of 80.0% (=12/15) means that only 3 of the 15 DC partici-
pants were misclassified by the SVMP1 classifier. The accuracy
achieved was 82.8%.
The logistic regression models ascertained that classification accu-
racy depended neither on the age at surgery nor on the period of
visual recovery: A statistically significant intercept term in both
experiments suggested that the classification accuracies for the mean
age at surgery and mean visual recovery period were significantly
above chance level (Exp. 1: bMPP1 = 1.367, SE = 0.535, p = .011;
bSVMP1 = 1.604, SE = 0.575, p = .005, Exp. 2: bMPP1 = 1.108, SE = 0.472,
p = .019; bSVMP1 = 1.160, SE = 0.440, p = .008). The independent varia-
bles, normalized age at surgery and normalized time since surgery,
on the other hand, did not have significant coefficients for any of thebiomarkers in any of the two experiments (Exp. 1: ps > .160, Exp. 2:
ps > .158).
Finally, we observed excellent to almost perfect inter-test classifi-
cation agreement for the participants who took part in both experi-
ments (Cohen’s k = 0.829, see Supplementary Materials S4. P1-Based
Biomarkers Exhibit High Test-Retest Reliability) [48,49].
5. Discussion
In two separate experiments involving visual event-related
potentials (VERPs) elicited by simple, high contrast visual grating
stimuli presented in different quadrants of the visual field, we aimed
to develop and validate an electrophysiological biomarker for the
classification of sight-restored patients who had suffered a transient
phase of bilateral cataracts, either congenital or developmental.
Based on previous reports of a reduced P1 amplitude in the VERPs of
sight-restored congenital but not developmental cataract patients
[9,12,24], we tested whether the P1 amplitude as a marker of extras-
triate cortical processing is capable of classifying vision-restored con-
genital cataract (CC) patients and distinguishing them from vision-
restored developmental cataract (DC) patients [25]. Two classification
scores were derived from the P1: (1) The mean P1 amplitude over
posterior electrodes after normalizing the scalp topography (MPP1),
and (2) a weighted sum of the normalized posterior P1 amplitudes
derived from a linear support vector machine (SVMP1). We made use
of the detailed information listed in the medical records of the partic-
ipating cataract patients (see Method: Participants) for labeling their
etiologies. Importantly, these criteria did not involve EEG-based
parameters. The classification results strongly suggest that the P1
amplitude is a robust electrophysiological biomarker for classifying
congenital cataract-reversal individuals, even after extensive recov-
ery periods since cataract removal surgery (at least one year and up
to 37 years in the present study sample, see also Methods: Partici-
pants).
Extensive functional reorganization of the extrastriate visual cor-
tex has been reported in vision-deprived non-human primates tested
after a short period (1  3 weeks) of visual recovery [26]. The present
results suggest that congenital blindness in humans leads to irrevers-
ible changes in the neural systems beyond the primary visual cortex,
which are discernible at an individual level using noninvasive and
readily accessible electrophysiological methods after sight restora-
tion and a substantial period of vision recovery. By contrast, using the
first cortical VERP (C1 wave) we have recently demonstrated evi-
dence for a retinotopic activation of early visual cortex in sight-
restored CC individuals. The C1 onset latencies were indistinguish-
able between CC patients and their matched controls, as in the DC
group [12]. A by and large preserved if at all enhanced C1 (difference)
wave but markedly reduced P1 wave excludes trivial accounts for the
high performance of P1-based biomarkers, such as poor fixation due
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individuals based on the normalized C1 wave amplitudes or the C1
difference waves was not possible (See section S3, Supplementary
Materials). The failure to classify a history of congenital pattern vision
deprivation based on the first visual cortical (difference) potential, in
contrast to the success of the P1-based biomarkers, additionally indi-
cates that the P1-based biomarkers were likely not driven by a gen-
eral reduction of the VERP in the CC group e.g. caused by nystagmus
or lack of fixation. To the best of our knowledge, the present study is
the first one reporting an electrophysiological classification process
for CC vs. DC individuals, or more generally, for sight recovery indi-
viduals with congenital vs. late onsets of visual impairments.
The persistent P1 wave reduction in sight recovery individuals,
observed following transient congenital pattern vision deprivation,
might have been caused by either a generally attenuated response
from extrastriate visual cortical circuits and/or by a lack of synchrony
of the elicited P1 wave across trials, leading to a reduced mean P1
amplitude. Recent research on strabismic as well as anisometropic
amblyopia has argued that a trial-to-trial latency difference of P1
activity might underlie a similar reduction of P1 wave amplitude
observed in the amblyopic eye compared to the fellow eye [50].
Visual experience seems to be necessary for the temporal tuning of
extrastriate cortex activity. Thus, the P1 reduction in CC individuals
in the present study might be driven by a similar mechanism. More-
over, the P1 wave has been associated with alpha-wave related inhib-
itory activity in the visual cortex [51]. According to the P1 inhibition
timing hypothesis, the alpha wave phase at the presentation of a
stimulus influences the P1 wave, reflecting inhibition-related activity
involved in suppressing task-irrelevant neural circuits [52]. In fact,
the P1 wave observed in the present study was larger over task-irrel-
evant ipsilateral scalp sites (see Fig. 3), in accord with this hypothesis.
Additional evidence for compromised alpha oscillatory activity in CC
individuals suggests that an altered excitatory-inhibitory balance
might be contributing to the P1-wave related biomarkers [13,53], in
line with non-human animal research indicating persistent changes
in inhibitory networks in response to binocular visual deprivation
[54].
The electrophysiological diagnostic approach developed in the
present study could augment existing methods for classifying con-
genital from developmental cataract-reversal individuals, and possi-
bly more generally, transient congenital from transient
developmental visual deprivation. This could be of considerable value
for establishing an etiology in the absence of reliable information
from other sources, or in the presence of symptom overlap at late
presentation. Childhood cataract has been reported to cause about
30% of all avoidable childhood blindness cases in low-income coun-
tries, where many of the late-treated individuals reside [1,14]. The
procedure developed in the present study is highly specific and thus
will aid prognostic estimates in patients consulting and rehabilitation
effort planning. For example, a strong reduction of the P1 wave in a
post-operative individual might indicate the need for more extensive
rehabilitation strategies for CC than for DC individuals after sight res-
toration. The issues associated with rehabilitation of sight restored
CC individuals go beyond the treatment of visual acuity problems.
For example, patients with a history of bilateral congenital cataracts
are more likely to suffer from face and motion processing related
deficits compared to individuals who had suffered from a period
of transient unilateral congenital visual deprivation, or bilateral
visual deprivation later in childhood [9,11,13,17]. Moreover, mul-
tisensory integration is partially compromised in sight restored
CC individuals, and there is evidence for an interference of coex-
isting auditory input on visual processing [5557]. Thus, pro-
posed multisensory rehabilitation approaches might well work
for sight restored DC patients but visual rehabilitation strategies
addressing different levels of visual processing might work best
for sight restored CC patients [58].Furthermore, the P1-based biomarker could aid clinical as well as
basic research. Outcomes of childhood cataract surgery, postsurgical
treatment, and rehabilitation planning are areas of active clinical
research [19,20], and these outcomes critically depend on cataract
etiology, interacting with the duration of transient blindness [4]. An
otherwise highly effective treatment (e.g. surgical procedure) might
show diverging outcomes in CC and DC patients. Thus, the treatment
would be evaluated differently depending on the proportion of CC
and DC patients in the sample. In fact, many investigations on child-
hood cataract to date have not distinguished between these two dis-
tinct patient groups [14], thus increasing the probability of
confounding outcomes and invalid conclusions, in particular severely
affecting studies spanning multiple centers in different countries
where congenital and developmental cataracts have different preva-
lences. A P1-based electrophysiological marker would contribute to
better stratify distinct patient groups and would therefore help
reducing error variance emerging from averaging across qualitatively
distinct clinical groups.
For basic research aiming at identifying the genetic and experi-
ence dependence of functional and structural brain development, a
reliable distinction between CC and DC patients is essential [59]. Dif-
ferences in neural and associated behavioral measures between
patients with a congenital vs. a late onset of transient blindness are
interpreted as evidence for sensitive periods in brain development,
that is, the crucial role of early experience for the typical develop-
ment of neural circuits. Neuroscience research in cataract-reversed
patients is one of the rare opportunities to investigate the neural
mechanisms associated with sensitive periods in humans [6062].
The results obtained from these populations allow, on the one hand,
understanding the role of visual experience in driving typical devel-
opment. On the other hand, these findings are not only important for
improving treatment of patients with sensory deficits, but addition-
ally for any type of program aiming at remediating aberrant early
sensory experience later in life. The present study in CC vs. DC indi-
viduals was possible due to access to detailed medical records with
pre- and post-surgery assessments of the eyes, family reports and
family history. However, in many if not most settings, especially in
developing countries, such detailed patient records are most of the
time unavailable. Therefore, a standardized electrophysiological clas-
sification method as suggested in the present study would greatly aid
patient group assignment across different centers and labs. How early
the P1 classification procedure is feasible after surgery, however, still
needs to be established. All sight recovery individuals in the present
study were tested after at least one year following surgical interven-
tion, likely providing considerable time for visual recovery. The time
course of P1 wave development in DC individuals after surgery is cru-
cial for the assessment of the biomarkers in a longitudinal setting. If a
typical P1 wave is observed in DC individuals immediately after sur-
gery, as the reduced P1 amplitude in CC individuals likely indicates
impaired extrastriate cortical development, we predict that P1 based
classification will work as soon as the patient can be tested post-sur-
gery. If the P1 wave conversely develops over a longer post-surgical
time course, systematic associations between the P1-based bio-
markers and behavioral measures will possibly offer informative
electrophysiological correlates of visual system recovery. In addition,
developmental cataract reversal individuals with a history of early-
onset, dense bilateral cataracts could eventually help pinpointing the
closure of the sensitive period for a typical P1 wave development. In
the present study, the accuracy of the biomarkers did not depend on
the age at surgery, or time since surgery, suggesting a high stability
of the P1 impairment in CC individuals. Moreover, the DC groups in
both experiments exhibited normalized posterior P1 amplitudes
which were indistinguishable from the typically sighted controls,
suggesting the existence of a sensitive period after which pattern
vision deprivation does not reduce the P1 amplitude. While we pre-
dominantly tested late treated congenital cataract patients (> 5
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and 5 cases in experiment 2, it remains an open issue how many
weeks of binocular deprivation must persist to cause reliable P1
amplitude reductions [10].
Finally, the robust performance of the biomarkers when tested in
a group of only CC and DC individuals excluding the control partici-
pants, who were tested in Germany, excludes factors related to eth-
nicity or culture driving the high classification performance.
In conclusion, the present study obtained and validated a reliable
and specific electrophysiological biomarker for classifying sight
recovery patients with a history of bilateral congenital vs. develop-
mental cataracts, which on the one hand will allow for tailored treat-
ment and rehabilitation efforts, and on the other hand will aid
clinical and basic research by reducing error variance due to averag-
ing across data from patients with heterogeneous etiologies.
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